Back to top
more

Medtronic (MDT)

(Delayed Data from NYSE)

$80.38 USD

80.38
5,028,304

-0.91 (-1.12%)

Updated Apr 24, 2024 04:00 PM ET

After-Market: $80.18 -0.20 (-0.25%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (152 out of 252)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for MDT

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Medtronic PLC falls in the month of April.

All items in Millions except Per Share data.

4/30/2023 4/30/2022 4/30/2021 4/30/2020 4/30/2019
Assets          
Cash & Equivalents 7,959 10,573 10,817 10,948 9,848
Receivables 5,998 5,551 5,462 4,645 6,222
Notes Receivable 0 0 0 0 0
Inventories 5,293 4,616 4,313 4,229 3,753
Other Current Assets 2,425 2,318 1,955 2,209 2,144
Total Current Assets 21,675 23,059 22,548 22,031 21,967
Net Property & Equipment 5,569 5,413 5,221 4,828 4,675
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 3,477 3,403 3,169 2,832 1,519
Intangibles 56,269 56,097 59,701 58,904 60,519
Deposits & Other Assets 3,959 3,008 2,443 2,094 1,014
Total Assets 90,948 90,981 93,083 90,689 89,694
Liabilities & Shareholders Equity 4/30/2023 4/30/2022 4/30/2021 4/30/2020 4/30/2019
Notes Payable 0 0 0 0 0
Accounts Payable 2,662 2,276 2,106 1,996 1,953
Current Portion Long-Term Debt 20 3,742 11 2,776 838
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 5,530 5,672 5,957 5,092 5,114
Income Taxes Payable 840 704 435 502 567
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 9,051 12,394 8,509 10,366 8,472
Mortgages 0 0 0 0 0
Deferred Taxes/Income 708 884 1,028 1,174 1,278
Convertible Debt 0 0 0 0 0
Long-Term Debt 24,344 20,372 26,378 22,021 24,486
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 5,180 4,610 5,564 6,256 5,246
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 39,283 38,260 41,481 39,817 39,482
Shareholders Equity 4/30/2023 4/30/2022 4/30/2021 4/30/2020 4/30/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 24,590 24,566 26,319 26,165 26,532
Retained Earnings 30,392 30,250 28,594 28,132 26,270
Other Equity -3,317 -2,094 -3,311 -3,425 -2,590
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 51,665 52,722 51,602 50,872 50,212
Total Liabilities & Shareholder's Equity 90,948 90,981 93,083 90,689 89,694
Total Common Equity 51,665 52,722 51,602 50,872 50,212
Shares Outstanding 1,330.40 1,341.50 1,348.00 1,340.10 1,341.10
Book Value Per Share 38.83 39.30 38.28 37.96 37.44

Fiscal Year End for Medtronic PLC falls in the month of April.

All items in Millions except Per Share data.

1/31/2024 10/31/2023 7/31/2023 4/30/2023 1/31/2023
Assets          
Cash & Equivalents 8,321 7,734 7,876 7,959 11,137
Receivables 5,968 5,934 5,806 5,998 5,887
Notes Receivable 0 0 0 0 0
Inventories 5,726 5,754 5,668 5,293 5,375
Other Current Assets 2,499 2,658 2,518 2,425 2,965
Total Current Assets 22,513 22,081 21,869 21,675 25,364
Net Property & Equipment 5,838 5,735 5,665 5,569 5,437
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 3,599 3,428 3,461 3,477 3,361
Intangibles 54,850 54,881 55,870 56,269 56,830
Deposits & Other Assets 4,036 3,962 3,912 3,959 3,142
Total Assets 90,836 90,087 90,776 90,948 94,134
Liabilities & Shareholders Equity 1/31/2024 10/31/2023 7/31/2023 4/30/2023 1/31/2023
Notes Payable 0 0 0 0 0
Accounts Payable 1,992 2,174 2,239 2,662 2,209
Current Portion Long-Term Debt 1,029 1,339 519 20 5,918
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 5,662 5,057 5,276 5,530 5,637
Income Taxes Payable 1,109 1,088 1,013 840 657
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 9,793 9,659 9,047 9,051 14,422
Mortgages 0 0 0 0 0
Deferred Taxes/Income 615 686 687 708 747
Convertible Debt 0 0 0 0 0
Long-Term Debt 24,153 23,741 24,463 24,344 22,210
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 4,280 5,214 5,180 5,138
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 38,840 38,440 39,410 39,283 42,516
Shareholders Equity 1/31/2024 10/31/2023 7/31/2023 4/30/2023 1/31/2023
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 24,589 24,580 24,587 24,590 24,513
Retained Earnings 30,661 30,256 30,265 30,392 30,117
Other Equity -3,255 -3,190 -3,486 -3,317 -3,012
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 51,996 51,647 51,366 51,665 51,618
Total Liabilities & Shareholder's Equity 90,836 90,087 90,776 90,948 94,134
Total Common Equity 51,996 51,647 51,366 51,665 51,618
Shares Outstanding 1,327.80 1,329.60 1,330.50 1,330.40 1,330.40
Book Value Per Share 39.16 38.84 38.61 38.83 38.80